The functional role of transition metals in poly(A) synthesis was elucidated by investigating the effect of the metal chelator O-Phenanthroline on purified nuclear poly(A) polymerase. This chelator inhibited the enzyme activity in a manner competitive with respect to the polynucleotide primer concentration. O-Phenanthroline was a non-competitive inhibitor with regard to ATP concentration and an ‘uncompetitive’ inhibitor with regard to dithiothreitol levels. The metal content of the purified enzyme preparations from rat liver and Morris hepatoma 3924A was determined using atomic absorption spectrometry. Of the transition metals measured, only zinc was present in detectable quantities, at levels less than 1 mol/mol of enzyme. Hepatoma enzyme contained 2-3 times as much zinc as the corresponding liver enzyme. Hepatoma poly(A) polymerase was also radioactively labelled in vivo by injection of tumor-bearing animals with 65Zn. Dialysis experiments with highly purified radiolabelled poly(A) polymerase showed that the enzyme · zinc complex was labile and that a reduction in 65Zn content correlated with a loss in enzyme activity. These data indicate that (a) poly(A) polymerase is a zinc-containing protein, (b) this metal plays a role in the interaction between enzyme and its polynucleotide primer, (c) relative to hepatoma poly(A) polymerase, the liver enzyme forms a less stable complex with zinc, and (d) the loss of zinc from poly(A) polymerase upon extensive purification may explain its low zinc content relative to that reported for other proteins.
No takes yet. Share an insight, caveat, or question.
Rose et al. (1978) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: